Mesoblast issues shares to Osiris Therapeutics after FDA approval of Ryoncil

Mesoblast Limited, a pioneering biotechnology company listed on the Australian Securities Exchange (ASX:MSB), has announced the issuance of 10.2 million ordinary shares to Osiris Therapeutics. ... Read More